Hence, further studies must be directed towards a better understanding of molecular mechanisms of tauopathies by examining tau filaments from the AD brain, which hopefully will improve diagnostics and accelerate the development of disease-modifying therapies. This evidence concerns the gene MAPT and Alzheimer disease.